STOCK TITAN

[Form 4] MongoDB, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

TriMas Corp. (TRS) Form 144 filing discloses a proposed sale of 63,965 common shares—about 0.16 % of the 40.64 M shares outstanding—valued at roughly $2.24 M. The seller intends to execute the trade through Fidelity Brokerage Services on Nasdaq around 29 Jul 2025. All shares were acquired in 2021 via stock-option exercises and restricted-stock vesting; no prior sales were reported in the last three months. Form 144 is a notice, not an executed sale, but it signals potential insider liquidity activity. Given the small percentage of total shares, the transaction should have limited market impact unless accompanied by further disposals.

TriMas Corp. (TRS) Deposito del Modulo 144 rivela una proposta di vendita di 63.965 azioni ordinarie—circa lo 0,16% delle 40,64 milioni di azioni in circolazione—valutate approssimativamente 2,24 milioni di dollari. Il venditore intende eseguire l'operazione tramite Fidelity Brokerage Services sul Nasdaq intorno al 29 luglio 2025. Tutte le azioni sono state acquisite nel 2021 tramite esercizio di opzioni su azioni e maturazione di azioni vincolate; non sono state segnalate vendite precedenti negli ultimi tre mesi. Il Modulo 144 è una notifica, non una vendita eseguita, ma indica una potenziale attività di liquidità da parte di insider. Considerata la piccola percentuale sul totale delle azioni, la transazione dovrebbe avere un impatto limitato sul mercato a meno che non sia seguita da ulteriori cessioni.

TriMas Corp. (TRS) Presentación del Formulario 144 revela una propuesta de venta de 63,965 acciones ordinarias—aproximadamente el 0,16% de las 40,64 millones de acciones en circulación—valoradas en alrededor de 2,24 millones de dólares. El vendedor planea ejecutar la operación a través de Fidelity Brokerage Services en Nasdaq alrededor del 29 de julio de 2025. Todas las acciones fueron adquiridas en 2021 mediante el ejercicio de opciones sobre acciones y la consolidación de acciones restringidas; no se reportaron ventas previas en los últimos tres meses. El Formulario 144 es un aviso, no una venta ejecutada, pero señala una posible actividad de liquidez de insiders. Dado el pequeño porcentaje del total de acciones, la transacción debería tener un impacto limitado en el mercado a menos que vaya acompañada de disposiciones adicionales.

TriMas Corp. (TRS) Form 144 제출은 약 0.16%에 해당하는 63,965주 보통주—총 4,064만 주 중—약 224만 달러 상당의 매도 제안을 공개했습니다. 매도자는 2025년 7월 29일경 Nasdaq에서 Fidelity Brokerage Services를 통해 거래를 실행할 계획입니다. 모든 주식은 2021년에 스톡옵션 행사와 제한주식 권리 확정으로 취득했으며, 최근 3개월간 이전 매도 보고는 없었습니다. Form 144는 거래 실행 통지가 아니라 잠재적 내부자 유동성 활동을 알리는 공지입니다. 전체 주식 대비 비중이 적어 추가 매도가 없으면 시장에 미치는 영향은 제한적일 것으로 보입니다.

TriMas Corp. (TRS) Dépôt du formulaire 144 révèle une proposition de vente de 63 965 actions ordinaires—soit environ 0,16 % des 40,64 millions d'actions en circulation—d'une valeur d'environ 2,24 millions de dollars. Le vendeur prévoit d'exécuter la transaction via Fidelity Brokerage Services sur le Nasdaq aux alentours du 29 juillet 2025. Toutes les actions ont été acquises en 2021 par l'exercice d'options d'achat d'actions et la levée de restrictions sur des actions bloquées ; aucune vente antérieure n'a été signalée au cours des trois derniers mois. Le formulaire 144 est un avis, non une vente réalisée, mais il indique une possible activité de liquidité des initiés. Étant donné la faible proportion du total des actions, la transaction devrait avoir un impact limité sur le marché, sauf si elle est accompagnée de cessions supplémentaires.

TriMas Corp. (TRS) Form 144 Einreichung offenbart einen geplanten Verkauf von 63.965 Stammaktien—etwa 0,16 % der 40,64 Mio. ausstehenden Aktien—im Wert von rund 2,24 Mio. USD. Der Verkäufer beabsichtigt, den Handel über Fidelity Brokerage Services an der Nasdaq um den 29. Juli 2025 durchzuführen. Alle Aktien wurden 2021 durch Ausübung von Aktienoptionen und die Freigabe von eingeschränkten Aktien erworben; in den letzten drei Monaten wurden keine vorherigen Verkäufe gemeldet. Form 144 ist eine Mitteilung, kein ausgeführter Verkauf, signalisiert jedoch potenzielle Insider-Liquiditätsaktivitäten. Aufgrund des geringen Anteils an den Gesamtaktien sollte die Transaktion begrenzte Marktauswirkungen haben, sofern sie nicht von weiteren Veräußerungen begleitet wird.

Positive
  • Sale equals only 0.16 % of shares outstanding, implying minimal dilution or supply pressure.
  • No other insider sales reported in the prior 3 months, limiting aggregation concerns under Rule 144(e).
Negative
  • Insider plans to liquidate $2.24 M of stock, which can be perceived as a confidence signal worth monitoring.

Insights

TL;DR: Modest insider sale (~0.16% of float); unlikely to move TRS shares materially.

Form 144 filings highlight insider intent rather than completed trades. Here, 63.9 k shares worth $2.24 M are slated for sale—insignificant versus TriMas’ 40.6 M shares outstanding and typical daily volume. The stock was acquired through routine equity-comp programs in 2021, suggesting profit-taking rather than deterioration in fundamentals. Absence of other recent sales reduces aggregation risk under Rule 144(e). Overall, I view the filing as neutral; investors should monitor additional filings to gauge broader insider sentiment.

TriMas Corp. (TRS) Deposito del Modulo 144 rivela una proposta di vendita di 63.965 azioni ordinarie—circa lo 0,16% delle 40,64 milioni di azioni in circolazione—valutate approssimativamente 2,24 milioni di dollari. Il venditore intende eseguire l'operazione tramite Fidelity Brokerage Services sul Nasdaq intorno al 29 luglio 2025. Tutte le azioni sono state acquisite nel 2021 tramite esercizio di opzioni su azioni e maturazione di azioni vincolate; non sono state segnalate vendite precedenti negli ultimi tre mesi. Il Modulo 144 è una notifica, non una vendita eseguita, ma indica una potenziale attività di liquidità da parte di insider. Considerata la piccola percentuale sul totale delle azioni, la transazione dovrebbe avere un impatto limitato sul mercato a meno che non sia seguita da ulteriori cessioni.

TriMas Corp. (TRS) Presentación del Formulario 144 revela una propuesta de venta de 63,965 acciones ordinarias—aproximadamente el 0,16% de las 40,64 millones de acciones en circulación—valoradas en alrededor de 2,24 millones de dólares. El vendedor planea ejecutar la operación a través de Fidelity Brokerage Services en Nasdaq alrededor del 29 de julio de 2025. Todas las acciones fueron adquiridas en 2021 mediante el ejercicio de opciones sobre acciones y la consolidación de acciones restringidas; no se reportaron ventas previas en los últimos tres meses. El Formulario 144 es un aviso, no una venta ejecutada, pero señala una posible actividad de liquidez de insiders. Dado el pequeño porcentaje del total de acciones, la transacción debería tener un impacto limitado en el mercado a menos que vaya acompañada de disposiciones adicionales.

TriMas Corp. (TRS) Form 144 제출은 약 0.16%에 해당하는 63,965주 보통주—총 4,064만 주 중—약 224만 달러 상당의 매도 제안을 공개했습니다. 매도자는 2025년 7월 29일경 Nasdaq에서 Fidelity Brokerage Services를 통해 거래를 실행할 계획입니다. 모든 주식은 2021년에 스톡옵션 행사와 제한주식 권리 확정으로 취득했으며, 최근 3개월간 이전 매도 보고는 없었습니다. Form 144는 거래 실행 통지가 아니라 잠재적 내부자 유동성 활동을 알리는 공지입니다. 전체 주식 대비 비중이 적어 추가 매도가 없으면 시장에 미치는 영향은 제한적일 것으로 보입니다.

TriMas Corp. (TRS) Dépôt du formulaire 144 révèle une proposition de vente de 63 965 actions ordinaires—soit environ 0,16 % des 40,64 millions d'actions en circulation—d'une valeur d'environ 2,24 millions de dollars. Le vendeur prévoit d'exécuter la transaction via Fidelity Brokerage Services sur le Nasdaq aux alentours du 29 juillet 2025. Toutes les actions ont été acquises en 2021 par l'exercice d'options d'achat d'actions et la levée de restrictions sur des actions bloquées ; aucune vente antérieure n'a été signalée au cours des trois derniers mois. Le formulaire 144 est un avis, non une vente réalisée, mais il indique une possible activité de liquidité des initiés. Étant donné la faible proportion du total des actions, la transaction devrait avoir un impact limité sur le marché, sauf si elle est accompagnée de cessions supplémentaires.

TriMas Corp. (TRS) Form 144 Einreichung offenbart einen geplanten Verkauf von 63.965 Stammaktien—etwa 0,16 % der 40,64 Mio. ausstehenden Aktien—im Wert von rund 2,24 Mio. USD. Der Verkäufer beabsichtigt, den Handel über Fidelity Brokerage Services an der Nasdaq um den 29. Juli 2025 durchzuführen. Alle Aktien wurden 2021 durch Ausübung von Aktienoptionen und die Freigabe von eingeschränkten Aktien erworben; in den letzten drei Monaten wurden keine vorherigen Verkäufe gemeldet. Form 144 ist eine Mitteilung, kein ausgeführter Verkauf, signalisiert jedoch potenzielle Insider-Liquiditätsaktivitäten. Aufgrund des geringen Anteils an den Gesamtaktien sollte die Transaktion begrenzte Marktauswirkungen haben, sofern sie nicht von weiteren Veräußerungen begleitet wird.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
MERRIMAN DWIGHT A

(Last) (First) (Middle)
C/O MONGODB, INC.
1633 BROADWAY, 38TH FLOOR

(Street)
NEW YORK NY 10019

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MongoDB, Inc. [ MDB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/25/2025 S(1) 1,000 D $245 1,104,316 D
Class A Common Stock 83,845 I Dwight A. Merriman Charitable Foundation(2)
Class A Common Stock 520,896 I By Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
2. The Dwight A. Merriman Charitable Foundation is a Delaware nonstock nonprofit corporation. The Reporting Person is deemed to have voting and investment power over the shares of MongoDB, Inc. Class A Common Stock held by the Dwight A. Merriman Charitable Foundation, but has no pecuniary interest in these shares.
3. These shares are held by The Dwight A. Merriman 2012 Trust for the benefit of the Reporting Person's children.
Remarks:
/s/ Paul Johnston, Attorney-in-Fact 07/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many TriMas (TRS) shares are being registered for sale?

63,965 common shares are listed in the Form 144 notice.

What is the market value of the proposed TRS share sale?

The aggregate market value is approximately $2.24 million.

When is the planned sale date for the TRS shares?

The filing cites an approximate sale date of 07/29/2025.

How large is the sale relative to TriMas’ shares outstanding?

The block represents about 0.16 % of the 40.64 million shares outstanding.

What exchange will the TRS shares be sold on?

The shares are slated for sale on the NASDAQ through Fidelity Brokerage Services.
Mongodb

NASDAQ:MDB

MDB Rankings

MDB Latest News

MDB Latest SEC Filings

MDB Stock Data

19.97B
79.03M
2.97%
86.63%
2.05%
Software - Infrastructure
Services-prepackaged Software
Link
United States
NEW YORK